Uncategorized

Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces the appointment of Dr. Samuel Zhang as its Global Chief Business Officer.

Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO) Read More »

Scroll to Top